comparemela.com

Latest Breaking News On - Drug controller general - Page 2 : comparemela.com

Docs support drug regulator s move to withdraw Olaparib for some cancer patients

Oncologists on Thursday supported the Drug Controller General of India's (DCGI) mandate to state authorities to withdraw AstraZeneca's anticancer generic drug Olaparib over safety concerns.Olaparib is a chemotherapy drug and is used to treat .

New delhiShyam aggarwalAbhishek shankarAstrazeneca olaparibRajeev singh raghuvanshiDr br ambedkar institute rotary cancer hospitalDepartment of radiation oncologyDrug controller generalAstrazeneca pharma indiaAssistant professorRadiation oncologyInstitute rotary cancer hospitalMedical oncologySir ganga ram hospital

cancer drugs | Drug Controller General of India orders withdrawal of AstraZeneca anti-cancer drug Olaparib tablets for certain treatments

cancer drugs | Drug Controller General of India orders withdrawal of AstraZeneca anti-cancer drug Olaparib tablets for certain treatments
telegraphindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraphindia.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

CGI orders withdrawal of cancer drug Olaparib for certain treatments

cgi orders withdrawal of cancer drug olaparib for certain treatments

New delhiAstrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

Docs support drug regulator s move to withdraw Olaparib for some cancer patients | MorungExpress

Docs support drug regulator s move to withdraw Olaparib for some cancer patients | MorungExpress
morungexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morungexpress.com Daily Mail and Mail on Sunday newspapers.

New delhiRajeev singh raghuvanshiAbhishek shankarShyam aggarwalAstrazeneca olaparibDr br ambedkar institute rotary cancer hospitalDepartment of radiation oncologyDrug controller generalAstrazeneca pharma indiaAssistant professorRadiation oncologyInstitute rotary cancer hospitalMedical oncologySir ganga ram hospital

India News | DCGI Orders Withdrawal of Cancer Drug Olaparib for Certain Treatments

Get latest articles and stories on India at LatestLY. The Drug Controller General of India has asked drug regulators in all states and Union territories to withdraw AstraZeneca's anti-cancer drug Olaparib tablets for treatment in patients who have received three or more prior lines of chemotherapy. India News | DCGI Orders Withdrawal of Cancer Drug Olaparib for Certain Treatments.

New delhiAstrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

vimarsana © 2020. All Rights Reserved.